Benkert, P., Meier, S., Schaedelin, S., Manouchehrinia, A., Yaldizli, Ö., Maceski, A., Oechtering, J., Achtnichts, L., Conen, D., Derfuss, T., Lalive, P. H., Mueller, C., Müller, S., Naegelin, Y., Oksenberg, J. R., Pot, C., Salmen, A., Willemse, E., Kockum, I., Blennow, K., Zetterberg, H., Gobbi, C., Kappos, L., Wiendl, H., Berger, K., Sormani, M. P., Granziera, C., Piehl, F., Leppert, D., Kuhle, J., , , Aeschbacher, S., Barakovic, M., Buser, A., Chan, A., Disanto, G., D'Souza, M., Du Pasquier, R., Findling, O., Galbusera, R., Hrusovsky, K., Khalil, M., Lorscheider, J., Mathias, A., Orleth, A., Radue, E., Rahmanzadeh, R., Sinnecker, T., Subramaniam, S., Vehoff, J., Wellmann, S., Wuerfel, J., & Zecca, C. (2022). serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet neurology, 21(3), 246–257. http://access.bl.uk/ark:/81055/vdc_100152255055.0x000010